OTC Markets OTCPK - Delayed Quote USD

Scancell Holdings plc (SCNLF)

0.1800

0.0000

(0.00%)

At close: January 10 at 3:00:00 PM EST

PharmaJet signs deal with Scancell for needle-free melanoma vaccine

Scancell is responsible for the clinical and regulatory development, as well as commercialisation of the combined product.

Medical Device Network 3 months ago

SCNLF
0.00%
Hedge funds investors control 42% of Scancell Holdings plc (LON:SCLP) and were rewarded last week after stock increased 13%

Key Insights Institutions' substantial holdings in Scancell Holdings implies that they have significant influence over...

Simply Wall St. 4 months ago

SCNLF
0.00%
With 47% stake, Scancell Holdings plc (LON:SCLP) seems to have captured hedge funds investors' interest

Key Insights Institutions' substantial holdings in Scancell Holdings implies that they have significant influence over...

Simply Wall St. 10 months ago

SCNLF
0.00%

Performance Overview

Return	SCNLF	FTSE 100
YTD	0.00%	+1.57%
1-Year	+36.36%	+7.35%
3-Year	-28.00%	+10.20%